Costs of Pharmacological and Non-Pharmacological Interventions in Interstitial Lung Disease Management in Germany
Sign Up to like & getrecommendations! Published in 2022 at "Respiration"
DOI: 10.1159/000526575
Abstract: Introduction: Interstitial lung diseases (ILDs) are associated with a high economic burden, yet prospective data of the German healthcare system are sparse. Objective: We assessed average ILD-related costs of pharmacological and non-pharmacological (hospitalizations, outpatient, rehabilitation,… read more here.
Keywords: pharmacological non; disease; non pharmacological; pharmacological costs ... See more keywords